172 related articles for article (PubMed ID: 8756926)
1. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences.
Outwater EK; Siegelman ES; Huang AB; Birnbaum BA
Radiology; 1996 Sep; 200(3):749-52. PubMed ID: 8756926
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
3. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
4. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases.
McNicholas MM; Lee MJ; Mayo-Smith WW; Hahn PF; Boland GW; Mueller PR
AJR Am J Roentgenol; 1995 Dec; 165(6):1453-9. PubMed ID: 7484585
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
6. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT.
Sebro R; Aslam R; Muglia VF; Wang ZJ; Westphalen AC
Abdom Imaging; 2015 Feb; 40(2):318-26. PubMed ID: 25095753
[TBL] [Abstract][Full Text] [Related]
7. Adrenal adenomas: relationship between histologic lipid and CT and MR findings.
Korobkin M; Giordano TJ; Brodeur FJ; Francis IR; Siegelman ES; Quint LE; Dunnick NR; Heiken JP; Wang HH
Radiology; 1996 Sep; 200(3):743-7. PubMed ID: 8756925
[TBL] [Abstract][Full Text] [Related]
8. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
Jhaveri KS; Wong F; Ghai S; Haider MA
AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
[TBL] [Abstract][Full Text] [Related]
10. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
Schwartz LH; Panicek DM; Koutcher JA; Brown KT; Getrajdman GI; Heelan RT; Burt M
Radiology; 1995 Nov; 197(2):421-5. PubMed ID: 7480686
[TBL] [Abstract][Full Text] [Related]
11. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
12. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
13. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications.
Adam SZ; Nikolaidis P; Horowitz JM; Gabriel H; Hammond NA; Patel T; Yaghmai V; Miller FH
Radiographics; 2016; 36(2):414-32. PubMed ID: 26849154
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
15. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
17. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?
Ho LM; Samei E; Mazurowski MA; Zheng Y; Allen BC; Nelson RC; Marin D
AJR Am J Roentgenol; 2019 Mar; 212(3):554-561. PubMed ID: 30620676
[TBL] [Abstract][Full Text] [Related]
18. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging.
Outwater EK; Siegelman ES; Radecki PD; Piccoli CW; Mitchell DG
AJR Am J Roentgenol; 1995 Sep; 165(3):579-83. PubMed ID: 7645474
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
20. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
